Novo Nordisk

NCT00410033

Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

NCT01516229

Special Survey for Long Term Application

NCT01579955

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

NCT01579968

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery

NCT01586936

Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

NCT01543867

Safety and Efficacy of Long-term Somatropin Treatment in Children

NCT00421850

Using Networks, Informatics, Technology, and Education in Care for People With Diabetes

NCT01498913

Observational Study of NovoNorm® in Subjects With Diabetes

NCT01487369

Special Survey of Production of Insulin Aspart Specific Antibody

NCT01487382

Special Survey for Paediatric Subjects

NCT01487408

Special Survey for Type 1 or Type 2 Diabetic Patients

NCT01009905

An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

NCT00822471

"Feasibility and Impact of ABCs of Diabetes Self-Management Education Program at an Urban Public Library"

NCT01492153

NovoLet® Surveillance Study on Using Human Insulin System in Indonesia

NCT01580605

French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

NCT01487421

An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime

NCT01543880

Safety and Efficacy of Long-term Somatropin Treatment in Adults

NCT00282594

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

NCT00306579

Myocardial Damage In Patients With Cerebral Infarction

NCT00435006

Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages

NCT01538576

Paediatric Subjects - Special Survey

NCT01538589

Special Survey for Patients With Type 1 or Type 2 Diabetes

NCT01476423

Observational Registry of the Treatment of Glanzmann's Thrombasthenia

NCT01542060

Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus

NCT00829569

n-3 Fatty Acid Infusion and Type 2 Diabetes

NCT01492218

Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction

NCT01492959

Observational Study With InnoLet® in Daily Clinical Practice

NCT00659295

Observational Study to Evaluate the Safety of Levemir® in Diabetes

NCT01498900

An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical Practice

NCT01536600

Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes

NCT01536613

Post Marketing Surveillance Study of Biphasic Insulin Aspart 30

NCT01542463

Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes

NCT00147836

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

NCT00124293

Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury

NCT00348231

Jikei Optimal Insulin Therapy in Type 2 Diabetes

NCT01490112

Surveillance Study of NovoRapid® for New Drug Re-examination

NCT00920725

Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA

NCT01487304

Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy

NCT00372125

Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome

NCT01604161

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

NCT00187993

Growth Hormone Treatment of Young Growth Hormone-Deficient Adults

NCT01492205

NovoLet® Acceptance Study Within the Hospital Practise in Indonesia

NCT01779921

Treatment of Congenital Factor VII Deficiency

NCT01486875

Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes

NCT01536639

Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes

NCT01536652

Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes

NCT01548248

Efficacy and Safety of Levemir® Used as Basal Insulin

NCT00283218

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.

NCT01548235

Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment

NCT01542424

An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus

NCT00960128

Observational Prospective Study on Patients Treated With Norditropin®

NCT01507454

Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

NCT01545791

Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes

NCT01536626

Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands

NCT00328133

The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry

NCT00824603

Impact of Continuing Medical Education (CME) Insulin Program

NCT00456105

The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes

NCT01542476

The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction

NCT00659282

Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes

NCT00564018

Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH

NCT01516242

Evaluation of Safety and Parameters of Application Technique

NCT01542489

Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos

NCT00457093

A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes

NCT01492166

Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice

NCT00763412

Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis

NCT00463411

Study of Male Osteoporosis and Aging

NCT00696995

An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment

NCT01500486

Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™

NCT01565733

Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes

NCT00715663

Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes

NCT00428207

Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

NCT01053234

Different Insulin Regimens and Postprandial Coagulation Activation

NCT01578135

French National Registry of Children Born Small for Gestational Age Treated With Somatropin

NCT00709917

Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes

NCT00776607

Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)

NCT00655044

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

NCT00665093

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

NCT00715351

Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

NCT00675220

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

NCT00700960

Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control

NCT00700908

Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 Diabetes

NCT00670683

Observational Study of Patients With Diabetes Using Levemir® FlexPen®

NCT00701155

Observational Study to Evaluate the Safety While Using Levemir®

NCT00497133

Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes

NCT00706017

Observational Study to Evaluate the Safety of Levemir® in Diabetes

NCT00712478

Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes

NCT00657319

Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins

NCT00665808

"Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During Real-life Usage in Germany"

NCT00698126

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

NCT00658099

Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®

NCT00671008

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

NCT00568568

Metabolic Studies- Interactions Between GH and Insulin in GHDA

NCT00670722

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

NCT00700765

Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

NCT00700830

Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes

NCT00704574

Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes

NCT00745433

Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide

NCT00853086

Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database

NCT00625040

Incretin Physiology and Beta-cell Function Before and After Weight-loss

NCT00915980

Meal Stimulating After Roux-en Y Gastric Bypass

NCT00655200

Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus

NCT00676741

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

NCT00687284

Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus

NCT00698269

An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment

NCT00657930

Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)

NCT00700648

An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects

NCT00703911

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

NCT00729898

Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes

NCT00735501

Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes

NCT00774579

The Effect of Growth Hormone Replacement on Liver Fat

NCT00687063

Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes

NCT00696163

Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes

NCT00825643

Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes

NCT01532661

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

NCT00675493

Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30

NCT00704223

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes

NCT00709475

Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus

NCT00709683

Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®

NCT00737776

Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes

NCT00697320

"Observational Study on the Efficacy and Safety of NovoSeven® During Real-life Usage in Germany"

NCT00699179

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

NCT00710619

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

NCT00715780

Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents

NCT00738153

An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes

NCT00697450

Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics

NCT00740519

Observational Study on Safety of Self-titration of Once Daily Levemir®

NCT00755833

Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

NCT00771680

Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

NCT00775736

Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin

NCT00509704

Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma

NCT00793884

Emory Latino Diabetes Education Program

NCT00705172

Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

NCT00788853

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Indonesia

NCT00789711

An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes

NCT00793273

Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.

NCT00806858

Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus

NCT00869908

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

NCT00805922

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Thailand

NCT00806936

Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects

NCT00849342

Observational Study on Levemir® in Obese Diabetic Patients

NCT00937703

Multicentric Evaluation of Two Telematics Systems in Type 2 Diabetic Patients in Failure of Oral Treatment and Having to Start Treatment by Basal Insulin